title: Should we consider ezetimibe to reach even lower LDL-C targets?
authors.affiliation: Department of Internal Medicine Medical School, University of Ioannina Ioannina , Greece.
authors.forename: Aris P
authors.initials: AP
authors.lastname: Agouridis
authors.forename: Dimitri P
authors.initials: DP
authors.lastname: Mikhailidis
mesh_terms: D003327:Coronary Disease / Q000209:etiology*; D050171:Dyslipidemias / Q000150:complications* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008297:Male; D055118:Medication Adherence
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors